Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Plasma NfL, clinical subtypes and motor progression in Parkinson's disease.

Parkinsonism & related disorders - 1 Jun 2021

Pilotto Andrea, Imarisio Alberto, Conforti Francesca, Scalvini Andrea, Masciocchi Stefano, Nocivelli Sara, Turrone Rosanna, Gipponi Stefano, Cottini Elisabetta, Borroni Barbara, Rizzetti Maria Cristina, Pizzi Marina, Bonanni Laura, Sturchio Andrea, Espay Alberto J, Zetterberg Henrik, Ashton Nicholas J, Hye Abdul, Padovani Alessandro

Abstract excerpt

INTRODUCTION: neurofilament light chain (NfL) levels have been proposed as reliable biomarkers of neurodegeneration in Parkinson's disease (PD) but the relationship between plasma NfL, clinical subtypes of PD and motor progression is still debated. METHODS: plasma NfL concentration was measured in 45 healthy controls and consecutive 92 PD patients who underwent an extensive motor and non-motor assessment at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Parkinson Disease
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aged, 80 and over

Share to Cognitive Dysfunction

Share to Disease Progression

Share to Follow-Up Studies

Share to Neurofilament Proteins

Share to Phenotype

Source

Identifiers

PMID: 33964785
DOI: 10.1016/j.parkreldis.2021.04.016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Plasma NfL, clinical subtypes and motor progression in Parkinson's disease.PMID 33964785Read ↗

Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease ProgressionSemantic proximity Read ↗

Serum neurofilament light as a biomarker for prognosis in patients with newly diagnosed Parkinson’s diseaseSemantic proximity Read ↗

Serum neurofilament light chain in LRRK2 related Parkinson's disease: A five years follow-up.Semantic proximity Read ↗

Neurofilament light chain as a mediator between LRRK2 mutation and dementia in Parkinson’s diseaseSemantic proximity Read ↗

Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p.A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative Study.Semantic proximity Read ↗

Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia SyndromesSemantic proximity Read ↗

Tau or neurofilament light-Which is the more suitable biomarker for Huntington's disease?Semantic proximity Read ↗

Plasma NfL as a prognostic biomarker for enriching HD-ISS stage 1 categorisation: a cross-sectional studySemantic proximity Read ↗

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysisSemantic proximity Read ↗

Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics.Semantic proximity Read ↗

Plasma neurofilament light levels show elevation prior to diagnosis of sporadic motor neuron disease in the UK Biobank cohortSemantic proximity Read ↗

Neurofilament light chain: a biomarker for genetic frontotemporal dementiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.